What are possible side effects of taking Enfiera 100mg/10ml Injection?

There are some common side effects of taking Enfiera 100mg/10ml Injection such as headache, weakness, infection, chills, decreased white blood cell count (neutrophils), fever, etc.

Can a patient with kidney related issue take Enfiera 100mg/10ml Injection?

Yes, it is safe to take Enfiera 100mg/10ml Injection in kidney related conditions if prescribed by the doctor.

Can a patient with liver related issue take Enfiera 100mg/10ml Injection?

Patients with liver related issues should avoid taking Enfiera 100mg/10ml Injection without consulting the doctor.

How to store Enfiera 100mg/10ml Injection?

Enfiera 100mg/10ml Injection should be store in a refrigerator (2 - 8°C) and do not freeze the injection.

Buy Enfiera 100mg/10ml Injection Online: Price, 40% Discount, Uses, and Side Effects

Name: Enfiera 100mg/10ml Injection
Brand: enfiera
Price: 4900 INR
Availability: InStock
Rating: 4.71 (7 reviews)

Description

Enfiera 100mg/10ml Injection contains Rituximab as an active ingredient that is a monoclonal antibody. It is used in the treatment of certain types of blood cancers such as chronic lymphocytic leukemia, non-Hodgkin lymphoma, and autoimmune disorders like rheumatoid arthritis, granulomatosis with polyangiitis and microscopic polyangiitis.

As it is a monoclonal antibody so It works by targeting the unusual activity of immune cells (B cells) in certain types of cancers and rheumatoid arthritis. It should be given by healthcare professional only do not self administer this injection.

Uses

Rheumatoid arthritis
Blood cancer (Chronic lymphocytic leukemia)
Non-Hodgkin lymphoma (NHL)
Granulomatosis with polyangiitis
Microscopic polyangiitis

Side Effects

Enfiera 100mg/10ml Injection can cause multiple side effects, most of which are mild to moderate and often temporary. Patients are advised to inform their healthcare provider immediately if symptoms stays for prolonged period of time.

Common side effects include:

Headache
Weakness
Infection
Chills
Decreased white blood cell count (neutrophils)
Fever
Infusion site reaction
Lymphopenia
Abdominal pain
Back pain

How To Use

The recommended dose of Enfiera 100mg/10ml Injection may vary according to the type of disease, as well as age, weight, and other health factors of the patients.
It should be given intravenously by a doctor or experienced nurse. Don't self- administer the injection and don't double the dose to compensate for the missed dose.

How It Works

Enfiera 100mg/10ml Injection contains Rituximab as an active ingredient that is a monoclonal antibody.

As it is a monoclonal antibody so it works by targeting the unusual activity of immune cells (B cells) in certain types of cancers and rheumatoid arthritis.

Safety Advice

Alcohol

Avoid the consumption of alcohol while taking Enfiera 100mg/10ml Injection, as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms

Pregnancy

Do not take Enfiera 100mg/10ml Injection without consulting the doctor in case of pregnancy, as it is an unsafe to take it during this period.

Breast Feeding

Enfiera 100mg/10ml Injection is safe to use while breastfeeding, if prescribed by the doctor. No dosage adjustment is necessary for this tablet as limited data is available that shows significant risk.

Driving

Enfiera 100mg/10ml Injection may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.

Kidney

Enfiera 100mg/10ml Injection is safe for use in kidney disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.

Liver

Consumption of Enfiera 100mg/10ml Injection should be avoided without informing the doctor if you have any liver-related issues.

FAQs

Enfiera 100mg/10ml Injection is prescribes to treat certain types of blood cancers such as chronic lymphocytic leukemia, non-Hodgkin lymphoma, and autoimmune disorders like rheumatoid arthritis, granulomatosis with polyangiitis and microscopic polyangiitis.

References

Chisari, C. G., Sgarlata, E., Arena, S., Toscano, S., Luca, M., & Patti, F. (2022). Rituximab for the treatment of multiple sclerosis: a review. Journal of neurology, 269(1), 159-183. https://pubmed.ncbi.nlm.nih.gov/33416999/
Plosker, G. L., & Figgitt, D. P. (2003). Rituximab: a review of its use in non-Hodgkin’s lymphoma and chronic lymphocytic leukaemia. Drugs, 63(8), 803-843. https://pubmed.ncbi.nlm.nih.gov/12662126/
Non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), granulomatosis with polyangiitis and microscopic polyangiitis.
Mok, C. C. (2014). Rituximab for the treatment of rheumatoid arthritis: an update. Drug design, development and therapy, 87-100. https://www.semanticscholar.org/paper/Rituximab-for-the-treatment-of-rheumatoid-an-update-Mok/f5c95f797ca31fdc933794ba5a4ea04f8ba57ce3
Provan, D., Butler, T., Evangelista, M. L., Amadori, S., Newland, A. C., & Stasi, R. (2007). Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults. haematologica, 92(12), 1695-1698. https://pubmed.ncbi.nlm.nih.gov/18055995/
Zaja, F., Battista, M. L., Pirrotta, M. T., Palmieri, S., Montagna, M., Vianelli, N., ... & Fanin, R. (2008). Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura. haematologica, 93(6), 930-933. https://pubmed.ncbi.nlm.nih.gov/18403395/
Bredemeier, M., de Oliveira, F. K., & Rocha, C. M. (2014). Low‐versus high‐dose rituximab for rheumatoid arthritis: a systematic review and meta‐analysis. Arthritis care & research, 66(2), 228-235. https://pubmed.ncbi.nlm.nih.gov/23983134/

Enfiera 100mg/10ml Injection

About The Product